Countering weapons of mass destruction is “an enduring mission of the U.S. Armed forces,” the US Army said last week in a new doctrinal publication.
Counter-WMD operations are defined as actions taken “against actors of concern to curtail the research, development, possession, proliferation, use, and effects of WMD, related expertise, materials, technologies, and means of delivery.”
See Combined Arms Countering Weapons of Mass Destruction, ATP 3-90.40, June 29, 2017.
The Army document does not refer to any specific countries such as North Korea.
Instead, it says generally that “Conventional forces and SOF [special operations forces] capabilities may be necessary to stop the movement of CBRN materials, WMD components and means of delivery, WMD-related personnel, or functional weapons into or out of specified areas or nations. Such actions may require boarding vessels and using search and detection capabilities to secure and seize shipments.”
Counter-WMD activities are directed not only at the weapons themselves but at the networks that produce, sponsor, fund and utilize them.
“Interacting with and engaging networks requires the use of lethal and nonlethal means to support, influence, or neutralize network members, cells, or an entire network. As part of this effort, commanders select, prioritize, and match effective means of interacting with friendly networks, influencing the neutral network, and neutralizing threat networks,” the new Army publication said.
“Commanders and staff utilize the targeting process to identify targets, determine the desired effects on those targets, predict secondary and tertiary effects, and plan lethal and nonlethal effects. This process enables the prosecution of targets to capitalize on and exploit targets of opportunity.”
We sat down with biomedical research pioneer Lee Hood to talk moonshots, metascience in medicine, and the Human Phenome Initiative.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”